Clinical trials essential in fighting mesothelioma

Clinical trials helpful in fighting mesothelioma

The National Institutes of Health reveals that clinical trial is essential for a patient’s medical advances. “Clinical trials serve to uncover better ways to treat, prevent, diagnose and understand human disease,” reports Mesothelioma Help. But what’s even better is that getting cleaning trials at the onset of mesothelioma cancer will do so much to help researchers obtain the necessary information information needed to push through with their studies in providing cure to this seemingly incurable disease.

MIT develops breakthrough cancer detection and diagnosis

MIT develops breakthrough cancer detection and diagnosis.

Another breakthrough is cancer detection and mesothelioma diagnosis has been developed, albeit in its infancy stage, by the Massachusetts Institute of Technology (MIT). This biomarker amplification system “could become a major breakthrough for early detection of cancers like mesothelioma,” reports Asbestos.com. 

Voters Pass Marijuana Reform, Providing Help to Suffering Cancer Patients

Marijuana is seen beneficial against mesothelioma cancer.

Mesothelioma cancer patients and families who prefer for alternative treatment options saw a glimpse of hope after voters in Massachusetts, Colorado and Washington voted that limited access to marijuana should be to provide cure against mesothelioma. A recent study in California revealed that a chemical compound found in marijuana has the potential to stop the metastasis of certain aggressive cancers like mesothelioma.

Study Demonstrates Mesothelioma Risk from Shipbuilding

Mid-20th century ship builders diagnosed with mesothelioma cancer

Shipbuilding in the 20th century have placed workers at risk of mesothelioma, reports Surviving Mesothelioma. A study in Italy revealed frequent occurrence of Mesothelioma from the 1940s to the 1960s in the shipbuilding town of Malfacone. Similarly, U.S. shipbuilders, particularly in Hamptons Road, Virginia revealed mesothelioma statistics that was 700% higher than the national average. 

Researchers Find Clue to Prevent Heart Damage in Mesothelioma Patients Treated with Doxorubicin

Doxorubicin, a drug against mesothelioma cancer,
could lead to heart failure.

Researchers at the University of Texas discovered the reason behind the cardiotoxity of Doxorubicin, a platinum-based drug used to combat mesothelioma, and certain types of cancer. According to Mesothelioma Help, the drug was discovered to cause heart failure in some patients.  The researchers said that their findings will help improve cancer care since it will lead to developing new, heart-friendly drugs to treat mesothelioma.

Tracking Genetic Susceptibility to Mesothelioma

Only 10 percent of those who are exposed to asbestos
really develop mesothelioma cancer

Mesothelioma Help reports that according to researchers from the Human Genetics Foundation in Turin, only 1 out of every 10 people exposed to asbestos are actually at risk pleural mesothelioma cancer. This is because of the genes, where “certain combinations of gene variants may create sensitivity to asbestos fibers, perhaps by altering cell division rate.”

Mesothelioma Study Suggests Trimodal Falls Short

Radical surgery not really effective in treating mesothelioma cancer.

Surviving Mesothelioma reports that the intense trimodal treatment approach, such as extrapleural pneumonectomy (EPP) does not really help patient survive mesothelioma cancer.  Extrapleural pneumonectomy (EPP) is a radical surgical approach for pleural mesothelioma, wherein the diseases mesothelium is removed as well as the nearest lung, other body linings, and all or part of the diaphragm. This procedure is followed by a chemotherapy and radiotherapy.  The sad thing is, trimodal approach has a high risk of serious complications and even death, although it also guaranteed longterm survival for a few lucky patients.